Peter Hoogerbrugge, PhD Pediatric Oncologist, Prinses Maxima Centrum, Utrecht

Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia

...Lees meer

0120HEM1291233

Stephan A. Grupp, MD, PhD Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia,

Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia

...Lees meer

0120HEM1291233

Francesco Passamonti, MD Dipartimento di Medicina e Chirurgia, Università dell'Insubria, Varese, Italy

Ruxolitinib for the Treatment of Inadequately Controlled Polycythemia Vera without Splenomegaly: 156-Week Follow-up from the Phase 3 Response-2 Study

...Lees meer

0120HEM1291431
×

Ask Speakers

×

Medical Information Request